Table 5.

Findings of CFR in some diseases associated to coronary microvascular dysfunction and in healthy controls [36]

Clinical setting	CFR
Hypertrophic cardiomyopathy	2.21 ± 0.2
Dilated cardiomyopathy	1.9 ± 0.2
Syndrome X	2.27 ± 0,3
Control group	3.3 ± 0.3